OncoTartis' Series B Round

OncoTartis raised a round of funding on July 01, 2016. Investors include BioProcess Capital Partners.

OncoTartis is a biotechnology company developing a novel category of anti-cancer drugs.…

Articles about OncoTartis' Series B Round: